Literature DB >> 20688886

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

J Bradley Layton1, Susan L Hogan, Caroline E Jennette, Barbara Kenderes, Jenna Krisher, J Charles Jennette, William M McClellan.   

Abstract

BACKGROUND AND OBJECTIVES: The United States Renal Data System (USRDS) is a commonly utilized database for epidemiologic research of ESRD patients. USRDS uses Medical Evidence Form 2728 to collect medical information about ESRD patients. The validity of the Form 2728 "primary cause of renal failure" field for glomerular diseases has not been evaluated, although inconsistencies between Form 2728 information and medical records have been documented previously with respect to comorbidities. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Form 2728 information was linked with renal biopsy results from the Glomerular Disease Collaborative Network (GDCN) for 217 patients with biopsy-confirmed glomerular diseases who had reached ESRD. Biopsy results were compared with the Form 2728 "primary cause of renal failure" field. Diseases were considered individually, and also categorized into commonly used disease groups. Percentage of agreement and disease-specific measures of validity were calculated.
RESULTS: Overall agreement between renal biopsy and Form 2728 was low (14.8% overall, 23.0% when categorized). Agreement was better after Form 2728 was revised in 1995 (10.0% before versus 23.2% after overall). The cause of ESRD field was left blank in 57% of the forms submitted for glomerular disease patients. Individual glomerular diseases had very low specificities, but tended to have high positive predictive values.
CONCLUSIONS: Form 2728 does not accurately reflect the renal pathology diagnosis as captured by biopsy. The large degree of missing data and misclassification should be of concern to those performing epidemiologic research using Form 2728 information on glomerular diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20688886      PMCID: PMC3001765          DOI: 10.2215/CJN.03550410

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  20 in total

1.  Differential risk of remission and ESRD in childhood FSGS.

Authors:  Debbie S Gipson; Hyunsook Chin; Trevor P Presler; Caroline Jennette; Maria E Ferris; Susan Massengill; Keisha Gibson; David B Thomas
Journal:  Pediatr Nephrol       Date:  2006-01-05       Impact factor: 3.714

2.  Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD.

Authors:  J Craig Longenecker; Josef Coresh; Michael J Klag; Andrew S Levey; Alice A Martin; Nancy E Fink; Neil R Powe
Journal:  J Am Soc Nephrol       Date:  2000-03       Impact factor: 10.121

3.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

4.  Thrombotic microangiopathy in United States long-term dialysis patients.

Authors:  Robert M Perkins; Joel C Reynolds; Tejinder S Ahuja; Thomas Reid; Lawrence Y Agodoa; Erin M Bohen; Christina M Yuan; Kevin C Abbott
Journal:  Nephrol Dial Transplant       Date:  2005-10-04       Impact factor: 5.992

5.  Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis.

Authors:  Susan L Hogan; Karen K Satterly; Mary Anne Dooley; Patrick H Nachman; J Charles Jennette; Ronald J Falk
Journal:  J Am Soc Nephrol       Date:  2001-01       Impact factor: 10.121

6.  Focal and segmental glomerulosclerosis in children: a longitudinal assessment.

Authors:  Olivia Boyer; Janelle K Moulder; Michael J G Somers
Journal:  Pediatr Nephrol       Date:  2007-04-17       Impact factor: 3.714

7.  Kidney disease in Bahrain: a biopsy based epidemiologic study.

Authors:  Ahmed Al Arrayed; Shameem Shariff; Majeda Musabah Al Maamari
Journal:  Saudi J Kidney Dis Transpl       Date:  2007-11

8.  Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults.

Authors:  Keisha L Gibson; Debbie S Gipson; Susan A Massengill; Mary Anne Dooley; William A Primack; Maria A Ferris; Susan L Hogan
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

9.  The outcome of renal transplantation among systemic lupus erythematosus patients.

Authors:  Madhukar Chelamcharla; Basit Javaid; Bradley C Baird; Alexander S Goldfarb-Rumyantzev
Journal:  Nephrol Dial Transplant       Date:  2007-07-19       Impact factor: 5.992

10.  Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.

Authors:  Christian Pagnoux; Susan L Hogan; Hyunsook Chin; J Charles Jennette; Ronald J Falk; Loïc Guillevin; Patrick H Nachman
Journal:  Arthritis Rheum       Date:  2008-09
View more
  37 in total

1.  Kidney Transplantation Outcomes across GN Subtypes in the United States.

Authors:  Michelle M O'Shaughnessy; Sai Liu; Maria E Montez-Rath; Colin R Lenihan; Richard A Lafayette; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System.

Authors:  Anna Broder; Wenzhu B Mowrey; Peter Izmirly; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04       Impact factor: 4.794

Review 3.  Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis.

Authors:  Moshe Vardi; Robert W Yeh; Charles A Herzog; Wolfgang C Winkelmayer; Soko Setoguchi; David M Charytan
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 8.237

4.  Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.

Authors:  Sarah Razzak Chaudhary; Biruh T Workeneh; Maria E Montez-Rath; Andrew R Zolopa; Paul E Klotman; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2015-07-13       Impact factor: 5.992

5.  Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.

Authors:  Laura C Plantinga; Cristina Drenkard; Rachel E Patzer; Mitchel Klein; Michael R Kramer; Stephen Pastan; S Sam Lim; William M McClellan
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

Review 6.  ESRD Databases, Public Policy, and Quality of Care: Translational Medicine and Nephrology.

Authors:  William M McClellan; Laura C Plantinga; Adam S Wilk; Rachel E Patzer
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-16       Impact factor: 8.237

7.  Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.

Authors:  Laura C Plantinga; Rachel E Patzer; Cristina Drenkard; Michael R Kramer; Mitchel Klein; S Sam Lim; William M McClellan; Stephen O Pastan
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-04       Impact factor: 4.794

8.  Asking dialysis patients about what they were told: a new strategy for improving access to kidney transplantation?

Authors:  Mark Unruh; Mary Amanda Dew
Journal:  J Am Soc Nephrol       Date:  2014-08-28       Impact factor: 10.121

Review 9.  Geographic information systems and chronic kidney disease: racial disparities, rural residence and forecasting.

Authors:  Rudolph A Rodriguez; John R Hotchkiss; Ann M O'Hare
Journal:  J Nephrol       Date:  2013 Jan-Feb       Impact factor: 3.902

10.  Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.

Authors:  Michelle M O'Shaughnessy; Maria E Montez-Rath; Richard A Lafayette; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2015-11-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.